Fundraising Fox
Atelerix
Newcastle, GB · 5 known investors
Find your way into Atelerix
Sign up to see every warm intro you have to Atelerix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atelerix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atelerix develops patented alginate hydrogel technology that stabilises cells, tissues, blood products, viruses and vectors at room temperature, removing the need for cryopreservation and cold-chain shipping. Spun out of Newcastle University, it serves researchers, biotech firms and diagnostics teams needing to store and transport biological samples.
Founders & leadership
Investors · 5
How we know: Cambridge Angels group's portfolio page · Not right? Tell us
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: O2h Ventures's portfolio page · Not right? Tell us
Frequently asked questions
- What does Atelerix do?
- Atelerix develops patented alginate hydrogel technology that stabilises cells, tissues, blood products, viruses and vectors at room temperature, removing the need for cryopreservation and cold-chain shipping. Spun out of Newcastle University, it serves researchers, biotech firms and diagnostics teams needing to store and transport biological samples.
- Who founded Atelerix?
- Atelerix was founded by Steve Swioklo.
- Who are Atelerix's investors?
- Atelerix's investors include Cambridge Angels group, Future Planet Capital, O2h Ventures, Oxford Technology Management, UK Innovation & Science Seed Fund.
- Where is Atelerix headquartered?
- Atelerix is headquartered in Newcastle, GB.